Invention Grant
- Patent Title: Nanolipidic particle assembly populations
-
Application No.: US15336104Application Date: 2016-10-27
-
Publication No.: US09987234B2Publication Date: 2018-06-05
- Inventor: Michael W. Fountain
- Applicant: Dermazone Solutions, Inc.
- Applicant Address: CA Calgary
- Assignee: NuVessl Inc.
- Current Assignee: NuVessl Inc.
- Current Assignee Address: CA Calgary
- Agency: Hemingway & Hansen, LLP
- Agent D. Scott Hemingway
- Main IPC: A61K9/51
- IPC: A61K9/51 ; A61K9/127 ; A61K8/14 ; A61K31/375 ; A61Q19/00 ; A61K9/14 ; A61K9/107 ; A61K31/122 ; A61K31/167 ; A61K31/522 ; A61K31/7048 ; A61K31/714 ; A61K8/42 ; A61K8/49 ; A61K8/60 ; A61K8/67 ; A61K9/00 ; A61K8/55

Abstract:
Nanolipidic Particles (NLPs) having average mean diameters of 1 nm to 20 nm are made from a precursor solution. NLPs can be loaded with a desired passenger molecule. Assemblies of these particles, called NLP assemblies, result in a vehicle population of a desired size. Single application or multifunction NLP assemblies are made from the loaded NLPs and range in size from about 30 to about 200 nm. A method of using preloaded NLPs to make larger carrier vehicles or a mixed population provides increased encapsulation efficiency. NLPs have application in the cosmetics, pharmaceutical, and food and beverage industries.
Public/Granted literature
- US20170042826A1 NANOLIPIDIC PARTICLE ASSEMBLY POPULATIONS Public/Granted day:2017-02-16
Information query